Agile Therapeutics reported $16.43M in Loan Capital for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Aceto ACET:US $ 0 0
Adma Biologics ADMA:US $ 94.36M 0.49M
Agile Therapeutics AGRX:US $ 16.43M 0.4M
Bayer BAYN:GR € 36974M 310M
Biomarin Pharmaceutical BMRN:US $ 1078.09M 0.98M
JAZZ PHA JAZZ:US $ 6253.65M 241.68M
Pacira Pharmaceuticals PCRX:US $ 326.15M 4.44M
Pain Therapeutics PTIE:US $ 0M 0M
Teva Pharmaceutical Industries TEVA:US $ 21037M 565M
Therapeuticsmd TXMD:US 171.74M 3.52M